Whole genome expression profiling associates activation of unfolded protein response with impaired production and release of epinephrine after recurrent hypoglycemia.

Recurrent hypoglycemia can occur as a major complication of insulin replacement therapy, limiting the long-term health benefits of intense glycemic control in type 1 and advanced type 2 diabetic patients. It impairs the normal counter-regulatory hormonal and behavioral responses to glucose deprivati...

Full description

Bibliographic Details
Main Authors: Juhye Lena Kim, Edmund F La Gamma, Todd Estabrook, Necla Kudrick, Bistra B Nankova
Format: Article
Language:English
Published: Public Library of Science (PLoS) 2017-01-01
Series:PLoS ONE
Online Access:http://europepmc.org/articles/PMC5325535?pdf=render
id doaj-8b72952cbea64e9f8be1f167e84b9fd5
record_format Article
spelling doaj-8b72952cbea64e9f8be1f167e84b9fd52020-11-24T22:18:39ZengPublic Library of Science (PLoS)PLoS ONE1932-62032017-01-01122e017278910.1371/journal.pone.0172789Whole genome expression profiling associates activation of unfolded protein response with impaired production and release of epinephrine after recurrent hypoglycemia.Juhye Lena KimEdmund F La GammaTodd EstabrookNecla KudrickBistra B NankovaRecurrent hypoglycemia can occur as a major complication of insulin replacement therapy, limiting the long-term health benefits of intense glycemic control in type 1 and advanced type 2 diabetic patients. It impairs the normal counter-regulatory hormonal and behavioral responses to glucose deprivation, a phenomenon known as hypoglycemia associated autonomic failure (HAAF). The molecular mechanisms leading to defective counter-regulation are not completely understood. We hypothesized that both neuronal (excessive cholinergic signaling between the splanchnic nerve fibers and the adrenal medulla) and humoral factors contribute to the impaired epinephrine production and release in HAAF. To gain further insight into the molecular mechanism(s) mediating the blunted epinephrine responses following recurrent hypoglycemia, we utilized a global gene expression profiling approach. We characterized the transcriptomes during recurrent (defective counter-regulation model) and acute hypoglycemia (normal counter-regulation group) in the adrenal medulla of normal Sprague-Dawley rats. Based on comparison analysis of differentially expressed genes, a set of unique genes that are activated only at specific time points after recurrent hypoglycemia were revealed. A complementary bioinformatics analysis of the functional category, pathway, and integrated network indicated activation of the unfolded protein response. Furthermore, at least three additional pathways/interaction networks altered in the adrenal medulla following recurrent hypoglycemia were identified, which may contribute to the impaired epinephrine secretion in HAAF: greatly increased neuropeptide signaling (proenkephalin, neuropeptide Y, galanin); altered ion homeostasis (Na+, K+, Ca2+) and downregulation of genes involved in Ca2+-dependent exocytosis of secretory vesicles. Given the pleiotropic effects of the unfolded protein response in different organs, involved in maintaining glucose homeostasis, these findings uncover broader general mechanisms that arise following recurrent hypoglycemia which may afford clinicians an opportunity to modulate the magnitude of HAAF syndrome.http://europepmc.org/articles/PMC5325535?pdf=render
collection DOAJ
language English
format Article
sources DOAJ
author Juhye Lena Kim
Edmund F La Gamma
Todd Estabrook
Necla Kudrick
Bistra B Nankova
spellingShingle Juhye Lena Kim
Edmund F La Gamma
Todd Estabrook
Necla Kudrick
Bistra B Nankova
Whole genome expression profiling associates activation of unfolded protein response with impaired production and release of epinephrine after recurrent hypoglycemia.
PLoS ONE
author_facet Juhye Lena Kim
Edmund F La Gamma
Todd Estabrook
Necla Kudrick
Bistra B Nankova
author_sort Juhye Lena Kim
title Whole genome expression profiling associates activation of unfolded protein response with impaired production and release of epinephrine after recurrent hypoglycemia.
title_short Whole genome expression profiling associates activation of unfolded protein response with impaired production and release of epinephrine after recurrent hypoglycemia.
title_full Whole genome expression profiling associates activation of unfolded protein response with impaired production and release of epinephrine after recurrent hypoglycemia.
title_fullStr Whole genome expression profiling associates activation of unfolded protein response with impaired production and release of epinephrine after recurrent hypoglycemia.
title_full_unstemmed Whole genome expression profiling associates activation of unfolded protein response with impaired production and release of epinephrine after recurrent hypoglycemia.
title_sort whole genome expression profiling associates activation of unfolded protein response with impaired production and release of epinephrine after recurrent hypoglycemia.
publisher Public Library of Science (PLoS)
series PLoS ONE
issn 1932-6203
publishDate 2017-01-01
description Recurrent hypoglycemia can occur as a major complication of insulin replacement therapy, limiting the long-term health benefits of intense glycemic control in type 1 and advanced type 2 diabetic patients. It impairs the normal counter-regulatory hormonal and behavioral responses to glucose deprivation, a phenomenon known as hypoglycemia associated autonomic failure (HAAF). The molecular mechanisms leading to defective counter-regulation are not completely understood. We hypothesized that both neuronal (excessive cholinergic signaling between the splanchnic nerve fibers and the adrenal medulla) and humoral factors contribute to the impaired epinephrine production and release in HAAF. To gain further insight into the molecular mechanism(s) mediating the blunted epinephrine responses following recurrent hypoglycemia, we utilized a global gene expression profiling approach. We characterized the transcriptomes during recurrent (defective counter-regulation model) and acute hypoglycemia (normal counter-regulation group) in the adrenal medulla of normal Sprague-Dawley rats. Based on comparison analysis of differentially expressed genes, a set of unique genes that are activated only at specific time points after recurrent hypoglycemia were revealed. A complementary bioinformatics analysis of the functional category, pathway, and integrated network indicated activation of the unfolded protein response. Furthermore, at least three additional pathways/interaction networks altered in the adrenal medulla following recurrent hypoglycemia were identified, which may contribute to the impaired epinephrine secretion in HAAF: greatly increased neuropeptide signaling (proenkephalin, neuropeptide Y, galanin); altered ion homeostasis (Na+, K+, Ca2+) and downregulation of genes involved in Ca2+-dependent exocytosis of secretory vesicles. Given the pleiotropic effects of the unfolded protein response in different organs, involved in maintaining glucose homeostasis, these findings uncover broader general mechanisms that arise following recurrent hypoglycemia which may afford clinicians an opportunity to modulate the magnitude of HAAF syndrome.
url http://europepmc.org/articles/PMC5325535?pdf=render
work_keys_str_mv AT juhyelenakim wholegenomeexpressionprofilingassociatesactivationofunfoldedproteinresponsewithimpairedproductionandreleaseofepinephrineafterrecurrenthypoglycemia
AT edmundflagamma wholegenomeexpressionprofilingassociatesactivationofunfoldedproteinresponsewithimpairedproductionandreleaseofepinephrineafterrecurrenthypoglycemia
AT toddestabrook wholegenomeexpressionprofilingassociatesactivationofunfoldedproteinresponsewithimpairedproductionandreleaseofepinephrineafterrecurrenthypoglycemia
AT neclakudrick wholegenomeexpressionprofilingassociatesactivationofunfoldedproteinresponsewithimpairedproductionandreleaseofepinephrineafterrecurrenthypoglycemia
AT bistrabnankova wholegenomeexpressionprofilingassociatesactivationofunfoldedproteinresponsewithimpairedproductionandreleaseofepinephrineafterrecurrenthypoglycemia
_version_ 1725782469702057984